Literature DB >> 11455001

Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.

Y Natkunam1, R A Warnke, K Montgomery, B Falini, M van De Rijn.   

Abstract

The gene encoding MUM1 was characterized as a possible translocation partner in chromosomal abnormalities involving a significant number of multiple myelomas. The overexpression of the MUM1 protein as a result of translocation t(6;14) (p25;q32) identified MUM1 as a putative regulatory molecule involved in B-cell differentiation and tumorigenesis. The expression of MUM1 protein in multiple myelomas supports this hypothesis. In the current study, using tissue microarray technology, we have tested the expression of the MUM1 protein in 1335 human malignancies and normal tissues. Our data show that the MUM1 protein is expressed in a wide spectrum of hematolymphoid neoplasms and in malignant melanomas but is absent in other human tumors. In addition, in tissue microarrays as well as in conventional paraffin sections, MUM1 staining was found to lack specificity in detecting plasmacytic differentiation as compared with two markers, CD138/Syndecan and VS38, commonly used in paraffin immunohistochemistry for detection of plasma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455001     DOI: 10.1038/modpathol.3880373

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  43 in total

1.  Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays.

Authors:  Chih Long Liu; Wijan Prapong; Yasodha Natkunam; Ash Alizadeh; Kelli Montgomery; C Blake Gilks; Matt van de Rijn
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

2.  Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.

Authors:  Matt van de Rijn; Charles M Perou; Rob Tibshirani; Phillippe Haas; Olli Kallioniemi; Juha Kononen; Joachim Torhorst; Guido Sauter; Markus Zuber; Ossi R Köchli; Frank Mross; Holger Dieterich; Rob Seitz; Doug Ross; David Botstein; Pat Brown
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry.

Authors:  Yuko Hirose; Yasufumi Masaki; Hiromi Karasawa; Kumiko Shimoyama; Toshihiro Fukushima; Hiroshi Kawabata; Noriyoshi Ogawa; Yuji Wano; Mamoru Ozaki
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

4.  Application of tissue microarrays to study the influence of dexamethasone on NF-kappaB expression of pancreas in rat with severe acute pancreatitis.

Authors:  Xi Ping Zhang; Ling Zhang; Hong Miao Xu; Yan Ping Xu; Qi Hui Cheng; Jian Mei Wang; Hai Ping Shen
Journal:  Dig Dis Sci       Date:  2007-06-16       Impact factor: 3.199

5.  Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Hua Tian; Yue-Hong Lai; Li Chen; Ling Zhang; Qi-Hui Cheng; Wei Yan; Yun Li; Qing-Yu Li; Qing He; Fei Wang
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

6.  CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.

Authors:  Robert F Luo; Shuchun Zhao; Robert Tibshirani; June H Myklebust; Mrinmoy Sanyal; Rosemary Fernandez; Dita Gratzinger; Robert J Marinelli; Zhi Shun Lu; Anna Wong; Ronald Levy; Shoshana Levy; Yasodha Natkunam
Journal:  Hum Pathol       Date:  2009-12-08       Impact factor: 3.466

7.  Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.

Authors:  Hiroyuki Momota; Yoshitaka Narita; Akiko M Maeshima; Yasuji Miyakita; Aya Shinomiya; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  J Neurooncol       Date:  2009-12-13       Impact factor: 4.130

8.  The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

Authors:  Dita Gratzinger; Shuchun Zhao; Robert West; Robert V Rouse; Hannes Vogel; Elena Cubedo Gil; Ronald Levy; Izidore S Lossos; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

9.  Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.

Authors:  Gabriela Gualco; Eduardo M Queiroga; Lawrence M Weiss; Claudete E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

10.  CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.

Authors:  Matthew W Anderson; Shuchun Zhao; Aharon G Freud; Debra K Czerwinski; Holbrook Kohrt; Ash A Alizadeh; Roch Houot; Denize Azambuja; Irene Biasoli; José Carlos Morais; Nelson Spector; Hernan F Molina-Kirsch; Roger A Warnke; Ronald Levy; Yasodha Natkunam
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.